Early Access — free while we kick the tires
EdgarHawk

Gupta Suneel

Chief Development Officer

Officer
1 filing analyzed · 1 company · Latest 2024-11-27

Companies

Company Buys Sells Direction
Protagonist Therapeutics, Inc PTGX 0 7 Net selling

Activity

November 2024
high
Sell
122,628 shares
$5,635,430
Significance 7/10

CDO Gupta sells 122,628 shares ($5.6M) at $45.96 avg, reducing stake by 31.4% over 2 days

Chief Development Officer Suneel Gupta executed 2 separate sales totaling 122,628 shares for $5,635,429.98 between November 25-26, 2024, at a blended average price of $45.96, reducing his holdings from 390,061 shares to 267,433 shares. This represents a 31.4% reduction in his shareholding at prices above the current market level of $44.95, which is down 6.7% over the past 30 days. The sale is particularly noteworthy given the company's fundamental profile: while annual revenue growth reached +125.7%, the company posted a net loss of $-33,210,000.00 in its latest fiscal year, and the recent quarterly revenue of $4,675,000.00 generates substantial losses, making profitability a key inflection point for PTGX's sustainability. An executive-level liquidation of this magnitude warrants scrutiny given the unprofitable operational status and recent price momentum deterioration.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access